Literature DB >> 27316912

Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Doungkamol Alongkronrusmee1, Terrance Chiang1, Richard M van Rijn2.   

Abstract

Delta opioid receptors (DORs) are heavily involved in alcohol-mediated processes in the brain. In this chapter we provide an overview of studies investigating how alcohol directly impacts DOR pharmacology and of early studies indicating DOR modulation of alcohol behavior. We will offer a brief summary of the different animal species used in alcohol studies investigating DORs followed by a broader overview of the types of alcohol behaviors modulated by DORs. We will highlight a small set of studies investigating the relationship between alcohol and DORs in analgesia. We will then provide an anatomical overview linking DOR expression in specific brain regions to different alcohol behaviors. In this section, we will provide two models that try to explain how endogenous opioids acting at DORs may influence alcohol behaviors. Next, we will provide an overview of studies investigating certain new aspects of DOR pharmacology, including the formation of heteromers and biased signaling. Finally, we provide a short overview of the genetics of the DORs in relation to alcohol use disorders (AUDs) and a short statement on the potential of using DOR-based therapeutics for treatment of AUDs.

Entities:  

Keywords:  Alcohol use disorder; Behavioral models; Delta opioid receptor; Enkephalin; Genetics; Medication development; Pharmacology

Mesh:

Substances:

Year:  2018        PMID: 27316912      PMCID: PMC5164984          DOI: 10.1007/164_2016_30

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  191 in total

1.  Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.

Authors:  L D Middaugh; B M Kelley; C H Groseclose; E R Cuison
Journal:  Pharmacol Biochem Behav       Date:  2000-01-01       Impact factor: 3.533

2.  Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.

Authors:  S S Negus; M B Gatch; N K Mello; X Zhang; K Rice
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

3.  Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress.

Authors:  S Matsuzawa; T Suzuki; M Misawa; H Nagase
Journal:  Brain Res       Date:  1998-08-24       Impact factor: 3.252

4.  Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence.

Authors:  P Franke; M M Nöthen; T Wang; H Neidt; M Knapp; D Lichtermann; O Weiffenbach; P Mayer; V Höllt; P Propping; W Maier
Journal:  Am J Med Genet       Date:  1999-10-15

5.  Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.

Authors:  P J Borg; D A Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-05       Impact factor: 3.000

Review 6.  From circuits to behaviour in the amygdala.

Authors:  Patricia H Janak; Kay M Tye
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

7.  Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats.

Authors:  P Fadda; S Tronci; G Colombo; W Fratta
Journal:  Alcohol Clin Exp Res       Date:  1999-08       Impact factor: 3.455

8.  Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.

Authors:  Roberto Ciccocioppo; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

9.  NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.

Authors:  Pattipati S Naidu; Aron H Lichtman; Carey C Archer; Everett L May; Louis S Harris; Mario D Aceto
Journal:  Eur J Pharmacol       Date:  2007-03-30       Impact factor: 4.432

10.  Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

Authors:  Albert J Arias; Stephen Armeli; Joel Gelernter; Jonathan Covault; Antero Kallio; Sakari Karhuvaara; Tiina Koivisto; Rauno Mäkelä; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

View more
  5 in total

1.  OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.

Authors:  Orna Levran; Matthew Randesi; Miriam Adelson; Mary Jeanne Kreek
Journal:  Transl Psychiatry       Date:  2021-05-25       Impact factor: 6.222

Review 2.  Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.

Authors:  Vladimir S Naumenko; Evgeni Ponimaskin
Journal:  Neural Plast       Date:  2018-04-03       Impact factor: 3.599

3.  G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.

Authors:  Anna M Gutridge; Meridith T Robins; Robert J Cassell; Rajendra Uprety; Kendall L Mores; Mee Jung Ko; Gavril W Pasternak; Susruta Majumdar; Richard M van Rijn
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

Review 4.  Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors.

Authors:  Yazan J Meqbil; Richard M van Rijn
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-15

5.  Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

Authors:  Arryn T Blaine; Yiming Miao; Jinling Yuan; Sophia Palant; Rebecca J Liu; Zhong-Yin Zhang; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.